Analysis: Saatvik Green Energy Ltd

NSE:SAATVIKGL Electric Equipment - General Market cap: ₹5.4K cr

Growth thesis

Saatvik Green Energy is an Indian solar manufacturer that currently earns nearly all revenue from PV module sales, with 4.8 GW operational capacity at its Ambala plant and a new 4 GW module line in Odisha scheduled for commercial production in Q1 FY27. The company is integrating backward into cell manufacturing, with a 2.4 GW first phase planned to begin production in H2 FY27 and a further 3.6 GW phase targeted for commissioning by mid-FY28, bringing total cell capacity to 6 GW. The module market is crowded with over 140 GW of domestic ALMM capacity, but cell manufacturing in India is scarce, and Saatvik's FY26 EBITDA margin of 12.78% reflects the current module-centric model; Q1 FY27 margin fell to 8.33% due to commodity volatility and geopolitical pressures, but the company expects significant improvement once cell production ramps.

The economic moat is not in module assembly but in the integrated stack. Cell production requires capital of roughly INR 1,700 crore for phase one and another INR 1,600-1,700 crore for phase two, plus regulatory qualification cycles. Customers in utility and C&I segments demand bankability, field performance history and Munich Re audits, which take years to establish. Saatvik also benefits from ALMM-II implementation from June 2026, shifting demand toward domestic cells, and the company's DCR eligibility allows it to sell cells at 18-20% margins in the retail and PM Surya Ghar segments. The in-house encapsulant plant, expanding from 2 GW to 5 GW, yields 5-10% cost savings on internal usage and external premium sales. These barriers are structural, not cyclical, though the module assembly part remains commoditized; the differentiation comes from owning the upstream.

The inflection point is the cell line. As of August 2026, the order book stands at 6.35 GW worth INR 8,200 crore, equal to 132% of current module capacity, with execution over 18 months. Management guides FY27 revenue around INR 6,000 crore, EBITDA margin of ~12%, and PAT margin of 6-7%, but expects H2 FY27 margins to improve as cell production starts. By mid-2028, the 6 GW cell capacity should be fully operational, along with 8.8 GW module capacity and 5 GW encapsulant capacity. Non-module businesses, including transformers, inverters, solar pumps and BESS, are targeted to reach 15% of revenue by next fiscal year, up from about 4-5% currently. The transformer business, entered via an 80% stake in Melcon, aims for INR 1,500 crore revenue in three to four years.

Management has a record of meeting and beating its own milestones. Historically, revenue growth exceeded 88% CAGR; 9M FY26 revenue grew 137% year on year. The Odisha 4 GW module line was commissioned by March 2026 as promised, and the 2 GW EPE film plant came online on schedule. The order book expanded from 4 GW at the start of FY26 to 5.05 GW in Q3 and 6.35 GW by August 2026. In the May 2026 call, management guided debt to equity of 1-1.5 times during the capex phase; current net debt is around INR 1,250 crore with a debt-to-equity of 0.99, and net debt is expected to peak at INR 2,200-2,400 crore. The company has committed to keeping this range and funding part of the expansion through accruals.

The earnings path is quantifiable: FY27 revenue of INR 6,000 crore at 12% EBITDA gives roughly INR 720 crore EBITDA, and PAT margin of 6-7% implies INR 360-420 crore PAT. With cell integration, management expects EBITDA margin to move to high double digits, implying over 15% in FY28 as the 6 GW cell stack ramps and non-module revenues contribute. What must be true is that the first cell line reaches 80% utilization by Q4 FY27, the second phase is commissioned by mid-FY28, and the war-related commodity and currency shocks do not push fixed-price contract margins below the guided band. The key falsifier is the H2 FY27 margin improvement; if cell ramp-up slips or margins remain below 12% for the full year, the thesis breaks. The tension between Q1's 8.33% margin and the 12% full-year guidance is a timing issue, not a structural one, as management has historically delivered on similar commitments.

Why is Saatvik Green Energy Ltd stock rising?

  • Solar cell manufacturing capacity scaled from 4.8 GW to 6 GW
  • Progressing towards ingot and wafer manufacturing with planned capacity of 6 GW
  • Encapsulant manufacturing capacity expanded from 2 GW to 5 GW
  • Odisha integrated module plant commercial production to start in Q1 FY27; cell production to begin in H2 FY27
  • Phase II cell capacity increased to 3.6 GW; full 6 GW cell capacity expected by mid-FY28

Research report

companyname: Saatvik Green Energy Limited ticker: SAATVIKGL sector: Solar / Renewable Energy Manufacturing, EPC & Energy Solutions Saatvik Green Energy is a solar photovoltaic module manufacturer that turned India's domestic-manufacturing mandate into a growth machine. It started in 2016 with a 125 MW line in Ambala, Haryana, and by FY26 operated 4.8 GW of module capacity across three plants on a single campus of about 724,000 square feet (Q1 FY26 call). The first full year as a listed company ...

Read the full report →

Catalysts

capex, margin expansion, regulatory approval, new product segment

Growth guidance

6 gigawatt solar cell production capacity to be commissioned by mid-2027 driven by backward integration and domestic manufacturing opportunities

Guidance no_data

Management consistency

overdeliver

RS rating: 35 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Saatvik Green Energy Ltd and 4,900+ companies.

Sign in
5-day free pass. No card required.